Literature DB >> 12626674

Veratridine block of rat skeletal muscle Nav1.4 sodium channels in the inner vestibule.

Ging Kuo Wang1, Sho-Ya Wang.   

Abstract

Veratridine (VTD) is an alkaloid toxin found in Liliaceae plants. VTD causes persistent opening of the voltage-gated Na+ channel and reduces its single-channel conductance by 75 %. The mechanisms for these different VTD actions are unknown. Recent reports indicate that the VTD receptor aligns closely with the local anaesthetic (LA) receptor, which resides at D1S6, D3S6 and D4S6 of the Na+ channel alpha-subunit. To study this alignment, we created a mutant with cysteine substitutions at three S6 residues (rNav1.4-N434C/L1280C/F1579C). Under voltage-clamp conditions, amitriptyline and bupivacaine remained as potent blockers of this mutant channel when expressed in human embryonic kidney cells, whereas VTD completely failed to cause persistent opening. Unexpectedly, VTD at 100 microM progressively blocked mutant currents by 90.4 +/- 1.6 % (n = 5), as assayed at 0.1 Hz for 15 min. This VTD block was reversed little during wash-off: approximately 70 % of mutant currents did not return in 30 min. An increase in channel opening either by repetitive pulses at 1 Hz or by the inhibition of the fast inactivation hastened the VTD block. Co-application of amitriptyline or bupivacaine, which targeted the LA receptor, prevented this VTD block. Our data suggest that (a) the VTD receptor and the LA receptor overlap extensively, (b) receptor-bound VTD lies in the inner vestibule, and (c) VTD blocks this mutant channel as a bona fide Na+ channel blocker. We propose that VTD likewise blocks the wild-type open Na+ channel, albeit partially, to decrease the unitary conductance and to stabilize the open conformation for persistent opening.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626674      PMCID: PMC2342907          DOI: 10.1113/jphysiol.2002.035469

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  32 in total

1.  Modification of wild-type and batrachotoxin-resistant muscle mu1 Na+ channels by veratridine.

Authors:  G K Wang; C Quan; M Seaver; S Y Wang
Journal:  Pflugers Arch       Date:  2000-04       Impact factor: 3.657

2.  Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit.

Authors:  V Yarov-Yarovoy; J Brown; E M Sharp; J J Clare; T Scheuer; W A Catterall
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

3.  The batrachotoxin receptor on the voltage-gated sodium channel is guarded by the channel activation gate.

Authors:  Hong-Ling Li; David Hadid; David S Ragsdale
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

4.  The open pore conformation of potassium channels.

Authors:  Youxing Jiang; Alice Lee; Jiayun Chen; Martine Cadene; Brian T Chait; Roderick MacKinnon
Journal:  Nature       Date:  2002-05-30       Impact factor: 49.962

5.  Role of amino acid residues in transmembrane segments IS6 and IIS6 of the Na+ channel alpha subunit in voltage-dependent gating and drug block.

Authors:  Vladimir Yarov-Yarovoy; Jancy C McPhee; Diane Idsvoog; Caroline Pate; Todd Scheuer; William A Catterall
Journal:  J Biol Chem       Date:  2002-07-18       Impact factor: 5.157

6.  Block of human heart hH1 sodium channels by amitriptyline.

Authors:  C Nau; M Seaver; S Y Wang; G K Wang
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

7.  Permeation of large tetra-alkylammonium cations through mutant and wild-type voltage-gated sodium channels as revealed by relief of block at high voltage.

Authors:  C J Huang; I Favre; E Moczydlowski
Journal:  J Gen Physiol       Date:  2000-04       Impact factor: 4.086

8.  Ionic pores, gates, and gating currents.

Authors:  C M Armstrong
Journal:  Q Rev Biophys       Date:  1974-05       Impact factor: 5.318

9.  Batrachotoxin-resistant Na+ channels derived from point mutations in transmembrane segment D4-S6.

Authors:  S Y Wang; G K Wang
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

10.  The inhibition of sodium currents in myelinated nerve by quaternary derivatives of lidocaine.

Authors:  G R Strichartz
Journal:  J Gen Physiol       Date:  1973-07       Impact factor: 4.086

View more
  8 in total

1.  Antagonism by local anesthetics of sodium channel activators in the presence of scorpion toxins: two mechanisms for competitive inhibition.

Authors:  Stanley Lee Son; Kin Wong; Gary Strichartz
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

2.  Mechanisms of action of ligands of potential-dependent sodium channels.

Authors:  D B Tikhonov
Journal:  Neurosci Behav Physiol       Date:  2008-07-18

3.  Veratridine modifies the gating of human voltage-gated sodium channel Nav1.7.

Authors:  Xiao-Yu Zhang; Rui-Yun Bi; Peng Zhang; Ye-Hua Gan
Journal:  Acta Pharmacol Sin       Date:  2018-06-27       Impact factor: 6.150

Review 4.  Sodium channels and pain: from toxins to therapies.

Authors:  Fernanda C Cardoso; Richard J Lewis
Journal:  Br J Pharmacol       Date:  2017-09-02       Impact factor: 8.739

5.  Inhibition of Sodium Ion Channel Function with Truncated Forms of Batrachotoxin.

Authors:  Tatsuya Toma; Matthew M Logan; Frederic Menard; A Sloan Devlin; J Du Bois
Journal:  ACS Chem Neurosci       Date:  2016-08-08       Impact factor: 4.418

6.  Actions of veratridine on tetrodotoxin-sensitive voltage-gated Na currents, Na1.6, in murine vas deferens myocytes.

Authors:  Hai-Lei Zhu; Richard D Wassall; Maki Takai; Hidetaka Morinaga; Masatoshi Nomura; Thomas C Cunnane; Noriyoshi Teramoto
Journal:  Br J Pharmacol       Date:  2009-06-22       Impact factor: 8.739

7.  Neurotoxins and their binding areas on voltage-gated sodium channels.

Authors:  Marijke Stevens; Steve Peigneur; Jan Tytgat
Journal:  Front Pharmacol       Date:  2011-11-09       Impact factor: 5.810

8.  Excitability constraints on voltage-gated sodium channels.

Authors:  Elaine Angelino; Michael P Brenner
Journal:  PLoS Comput Biol       Date:  2007-09       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.